Adverse Events Associated with Disease-Modifying Drugs for Multiple SclerosisNeurol 102:e208006, Ng, HS.,et al, 2024
Monoclonal Antibody Therapies and Neurologic DisordersArch Neurol 65:1162-1165, Novack,J.C.,et al., 2008